Abstract
Uveitis is associated with various infectious and autoimmune diseases and is one of the leading causes of blindness worldwide. The different drugs used in the treatment of uveitis have severe side effects, which stimulates the search for new therapeutic alternatives. In recent years, the role of anti-inflammatory protein annexin A1 (AnxA1) in ocular inflammatory processes has been investi…